Thomas Willigenburg

Chapter 1 30 87. Gontero P, Marra G, Alessio P, Filippini C, Oderda M, Munoz F, et al. Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches. J Urol 2019;202:725–31. 88. Uddin Ahmed H, Cathcart P, Chalasani V, Williams A, McCartan N, Freeman A, et al. Whole-gland salvage high-intensity focused ultrasound therapy for localised prostate cancer recurrence after external beam radiation therapy. Cancer 2012;118:3071–8. 89. Cellini N, Morganti AG, Mattiucci GC, Valentini V, Leone M, Luzi S, et al. Analysis of Intraprostatic Failures in Patients Treated With Hormonal Therapy and Radiotherapy : Implications for Conformal Therapy Planning. Int J Radiat Oncol Biol Phys 2002;53:595–9. 90. Pucar D, Hricak H, Shukla-Dave A, Kuroiwa K, Drobnjak M, Eastham J, et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys 2007;69:62–9. 91. Kunogi H, Wakumoto Y, Yamaguchi N, Horie S, Sasai K. Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature. J Contemp Brachytherapy 2016;8:165–72. 92. Maenhout M, Peters M, van Vulpen M, Moerland MA, Meijer RP, van den Bosch MAAJ, et al. Focal MRIGuided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer. Technol Cancer Res Treat 2017;16:1194–201. 93. Zamboglou C, Rischke H-C, Meyer PT, Knobe S, Volgeova-Neher N, Kollefrath M, et al. Single fraction multimodal image guided focal salvage high-doserate brachytherapy for recurrent prostate cancer. J Contemp Brachytherapy 2016;8:241–8. 94. Peters M, Maenhout M, van der Voort van Zyp JRN, Moerland MA, Moman MR, Steuten LMG, et al. Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life. Radiother Oncol 2014;112:77–82. 95. Murgic J, Morton G, Loblaw A, D’Alimonte L, Ravi A, Wronski M, et al. Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial. Int J Radiat Oncol Biol Phys 2018;102:561–7. 96. Hsu CC, Hsu H, Pickett B, Crehange G, Hsu I-CJ, Dea R, et al. Feasibility of MR imaging/MR spectroscopyplanned focal partial salvage permanent prostate implant (PPI) for localised recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys 2013;85:370–7. 97. Jiang P, van der Horst C, Kimmig B, Zinsser F, Poppe B, Luetzen U, et al. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome. Brachytherapy 2017;16:186–92. 98. Chitmanee P, Tsang Y, Tharmalingam H, Hamada M, Alonzi R, Ostler P, et al. Single-Dose Focal Salvage High Dose Rate Brachytherapy for Locally Recurrent Prostate Cancer. Clin Oncol 2020;32:259–65. 99. Slevin F, Hodgson S, Rodda SL, Bownes P, Bottomley D, Adiotomre E, et al. Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer. Clin Transl Radiat Oncol 2020;23:20–6. 100. Kongnyuy M, Berg CJ, Kosinski KE, Habibian DJ, Schiff JT, Corcoran AT, et al. Salvage focal cryosurgery may delay use of androgen deprivation therapy in cryotherapy and radiation recurrent prostate cancer patients. Int J Hyperth 2017;33:810–3. 101. Li Y-H, Elshafei A, Agarwal G, Ruckle H, Powsang J, Jones JS. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry. Prostate 2015;75:1–7. 102. de Castro Abreu AL, Bahn D, Leslie S, Shoji S, Silverman P, Desai MM, et al. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU Int 2013;112:298–307. 103. Bomers JGR, Overduin CG, Jenniskens SFM, Cornel EB, van Lin ENJT, Sedelaar JPM, et al. Focal Salvage MR Imaging–Guided Cryoablation for Localised Prostate Cancer Recurrence after Radiotherapy: 12-Month Follow-up. J Vasc Interv Radiol 2020;31:35–41. 104. Bomers JGR, Yakar D, Overduin CG, Sedelaar JPM, Vergunst H, Barentsz JO, et al. MR imaging-guided focal cryoablation in patients with recurrent prostate cancer. Radiology 2013;268:451–60. 105. Wenske S, Quarrier S, Katz AE. Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre. Eur Urol 2013;64:1–7.

RkJQdWJsaXNoZXIy MTk4NDMw